initially got a rash around the injection site; whole body rash/ I have developed rashes over my entire body; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 45-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for Injection), dose 1 via an unspecified route of administration, administered in Arm Left on 29Mar2021 12:00 (Batch/Lot Number: EP7534) as 1ST DOSE, SINGLE DOSE and dose 2 via an unspecified route of administration, administered in arm left on 20Apr2021 12:00 (Batch/Lot Number: EW0162), at 2nd dose, single dose for covid-19 immunisation. Medical history included on an unspecified date Panhypopituitarism, secondary hypogonadism, low thyroid, and adult growth hormone deficiency, ventriculo-peritoneal shunt, migraines, seizures, super-cellar arachnoid cyst, lack of energy and exercise capacity, no libido, nonfunctioning pituitary gland, brain surgeries (6 brain surgeries to treat hydrocephalus secondary to a super-cellar arachnoid cyst), VP shunt (Ventriculo-peritoneal shunt), on an unspecified date in 1993 hydrocephalus secondary, on an unspecified date in 1998 low testosterone level. Concomitant medications included botulinum toxin type a (BOTOX) taken for migraine; galcanezumab (EMGALITY [GALCANEZUMAB]) taken for migraine; lamotrigine (LAMICTAL) taken for seizure; levetiracetam (KEPPRA) taken for seizure. The patient previously took, humatrope for adult growth hormone deficiency, synthroid for low thyroid level, allopurinol (ELAVIL) and experienced drug hypersensitivity, metformin and experienced drug hypersensitivity, Cytomel 5 mcg. Prior to vaccination, the patient was not diagnosed with COVID. Since the vaccination, the patient has not been tested for COVID-19. On an unspecified date in 2021 the patient had whole body rash. On 22Apr2021 12:00 he initially got a rash around the injection site, which he heard was to be expected (COVID Arm). However, he has developed rashes over my entire body. These rashes developed gradually. First, it was the rash around the injection site, but that went away. Then, a rash developed further down the arm that he received the vaccine in (Left Arm), including on my hand. he has since developed rashes on my abdomen, right arm, thighs, legs and feet. he also has a breakout on my back. he submitted a report on the side effects (whole body rash) that he experiencing as a result of getting both shots of the Pfizer COVID-19 vaccine. he has whole body rashes that have developed since he got the second dose of the Pfizer COVID-19 vaccine. He first COVID-19 vaccine shot (Pfizer) was on 29Mar2021. He second dose of the Pfizer COVID-19 vaccine was administered on 20Apr2021. Adverse event resulted in emergency room visit and physician office visit. Patient received treatment for the events. Physician prescribed Triamcinolone Acetonide Cream USP, 0.5% with a total quantity of 45 grams. Three 15 gram tubes to treat the rashes. This treatment hasn't worked and, in fact, the rashes have spread. Because of this, patient PCP referred patient to a dermatologist, but that appointment isn't until next month. Furthermore, How do patient get compensated for the money patient was out of pocket to treat patient whole body rash. Furthermore, patient also need to know how patient would be compensated for the money patient have paid out of pocket and would pay out of pocket in the future due to the rashes patient have developed. Keep in mind, this isn't just the rash that developed around the injection site, but also rashes that have developed elsewhere on patient body after getting the second dose of the Pfizer COVID vaccine. Also, patient have pre-existing health conditions. These include having had 6 brain surgeries to treat hydrocephalus secondary to a super-cellar arachnoid cyst. As a result of my surgeries, patient now have a non functioning pituitary gland. In 1998 patient was initially diagnosed with a low testosterone level by pediatric Neurosurgeon. Patient was 21 at that time, however, patient had been a patient at Children's since the age of 16 or 17. Patient was referred to for the hydrocephalus in 1993. Anyway, after the diagnosis of the low testosterone level in 1998, patient was referred to the physician. That is where patient saw Endocrinologist. On patient initial visit with physician, he prescribed the testosterone replacement. He then went on to talk about patient other symptoms, which included lack of energy and exercise capacity, no libido, among other symptoms. recommended patient be tested for Adult Growth Hormone Deficiency (AGHD). Patient was enrolled in the HyPOCCS study, which covered the cost of the testing, as well as the treatment of the eventual diagnosis of AGHD. Patient was started on Humatrope later in 1998. Of course, Patient was also taking my testosterone replacement as well. Later on, when patient switched to another Endocrinologist closer to where patient live, he diagnosed patient with a low thyroid level. Patient was started on Synthroid, however, there was low T4 to T3 conversion. As a result, patient was also put on 5 mcg of Cytomel. Of course, this Endocrinologist was also treating my other hormone deficiencies as well. The seriousness of the events was reported as non-serious. Outcome of the events was not resolved.   Information on Lot/Batch number was available. Additional information has been requested.